Publication: Normal range of serum highly-sensitive troponin-T in patients with chronic kidney disease stage 3-5.
Issued Date
2012-02-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-84862295350
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. Vol.95 Suppl 2, (2012)
Suggested Citation
Thunnop Chotivanawan, Rungroj Krittayaphong Normal range of serum highly-sensitive troponin-T in patients with chronic kidney disease stage 3-5.. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. Vol.95 Suppl 2, (2012). Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/14977
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Normal range of serum highly-sensitive troponin-T in patients with chronic kidney disease stage 3-5.
Author(s)
Other Contributor(s)
Abstract
Serum troponin-T concentrations are commonly increased in chronic kidney disease (CKD) without acute coronary syndrome. Highly-sensitive troponin-T the new tool that helpful for diagnosis of acute coronary syndrome, provides few data about normal value in patients with chronic kidney disease. The authors studied 89 patients with CKD stage 3-5: 40 had CKD stage 3, 26 had CKD stage 4 and 23 had CKD stage 5. Serum samples were collected for the analysis of highly-sensitive troponin-T levels. The values of highly-sensitive troponin-T of the total group and each CKD stage were presented. The level of highly-sensitive troponin-T in patients with CKD stage 3-5 was 0.044 +/- 0.076 ng/ml. For CKD stages 3, 4 and 5 levels were 0.015 +/- 0.016, 0.043 +/- 0.056, 0.098 +/- 0.121 ng/ml, respectively. 95th percentile of the total group was 0.139 ng/ml. 95th percentile for stage 3, 4 and 5 were 0.052, 0.136, 0.297 ng/ml, respectively. 95th percentile for highly-sensitive troponin-T of patients with CKD stage 3-5 was 0.139 ng/ml. This number may be considered as the cut-off value for diagnosis of acute myocardial infarction.